Get Started

GTBP

NASD GT Biopharma Inc
Oct 23, 2026 · 7:53 PM ET LAST TRADE Market Closed

$5.41 ↓ -0.05 (-0.96%) Trading Down from the previous close of $5.46, $0.29 below the day’s high of $5.70

YTD change
-72.45%
vs 20-day SMA
-16.51%
vs 200-day SMA
-46.48%

Price ranges

Previous day
$5.28 $5.57
open $5.37 close $5.52
+$0.15 (+2.79%)
Today
$5.31 $5.70
open $5.58 now $5.41
-$0.17 (-3.09%)
Past week
$5.28 $7.49
from $7.36 now $5.41
-$1.95 (-26.53%)
Past month
$5.28 $7.50
from $6.83 now $5.41
-$1.42 (-20.83%)
This year
$0.22 $19.63
from $19.63 now $5.41
-$14.22 (-72.45%)

Price & Performance

+5.16 (+1438.03%) / 6M

$-0.6701$3.73$8.14$12.54Apr 23Jul 24Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $470,475.00
  • GTBP is down 72% since the beginning of the year
  • GTBP is down 70% over the past 12 months
  • GTBP is down 21% over the past 1 month
  • 13% of all GTBP investors are betting against GTBP

GTBP reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +655.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-3
Earnings momentum -20.0% Quarterly EPS growth
Quarterly change -20.0%

Valuation

P/E ratio N/A
Enterprise value $3.5M
Beta 0.43

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$5.1M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $11.1M

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on its proprietary TriKE and Dual Targeting TriKE platforms. Its product candidates include GTB-3650, a CD33-targeted therapy for relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome, and GTB-5550, a B7-H3-targeted therapy for solid tumors. The company was founded in 1965 and is headquartered in San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,306.69 +2.83%
JNJ Johnson & Johnson $267.61 +3.81%
ABBV AbbVie, Inc. $285.19 +0.14%
MRK Merck & Co., Inc. $147.24 -1.76%
RHHBY Roche Holding Ltd Sponsored ADR $59.62 +0.86%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.